Next Article in Journal
Alternative Sigma Factors of RNA Polymerase as Master Regulators in the Pathogenic Spirochaete Leptospira interrogans
Previous Article in Journal
Eighteen Years of Human Rhinovirus Surveillance in the Republic of Korea (2007–2024): Age- and Season-Specific Trends from a Single-Center Study with Public Health Implications
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System (T3SS) and Core Effector Proteins in Enteropathogenic Escherichia coli (EPEC) Strains Isolated from Food-Producing Animals and Products of Animal Origin

1
Bacteriology Division, Agricultural Research Council-Onderstepoort Veterinary Research, Onderstepoort 0110, South Africa
2
Department of Agriculture and Animal Health, Science Campus, University of South Africa, Florida 1709, South Africa
3
Department of Biochemistry, Genetics and Microbiology, University of Pretoria, Pretoria 0001, South Africa
4
Centre for Bioinformatics and Computational Biology, University of Pretoria, Pretoria 0001, South Africa
5
Department of Biochemistry, University of Johannesburg, Auckland Park, Johannesburg 2001, South Africa
6
Center on Emerging Infectious Diseases, Boston University, 111 Cummington Mall, Suite 140, Boston, MA 02215, USA
*
Author to whom correspondence should be addressed.
Pathogens 2025, 14(11), 1099; https://doi.org/10.3390/pathogens14111099
Submission received: 10 September 2025 / Revised: 3 October 2025 / Accepted: 6 October 2025 / Published: 29 October 2025

Abstract

Enteropathogenic Escherichia coli (EPEC) is a significant diarrheagenic pathotype responsible for severe gastrointestinal infections, particularly in vulnerable populations. The aim of this study is to utilize genome-based in silico analysis to study the structural and functional characteristics of the Type III Secretion System (T3SS) and its core effector proteins in EPEC strains. Representative proteins were selected, with particular interest placed on EscV and EscD as major parts of the export apparatus and the basal body, while the EspA effector protein forms the filamentous structure. Several in silico-based techniques were employed, revealing key structural proteins, core effectors, and adhesion-related proteins among the sequenced isolates. Of the 27 isolates analyzed, only 3 (11%) were found to carry LEE-encoded proteins associated with T3SS structural components (escV, escN, escD, and escU) and core effector proteins (espA, espD, espG, and eae). Structural predictions and Ramachandran plot validations suggested stability and potential functional conservation of T3SS proteins, with EscV and EspA selected for detailed 3D structural modelling. Insights into transmembrane domains, protein–protein interaction, and secondary structures were obtained, providing a comprehensive understanding of T3SS assembly and function. These findings suggest that the T3SS in EPEC consists of stable proteins that enable the system to remain functional. The structural and functional properties of the LEE genes encoding the T3SS in the EPEC pathotype represent promising targets for developing virulence blockers to disrupt the pathogenesis of a broad range of bacteria. This study is the first to report EPEC strains with functional T3SS in South Africa, emphasizing the importance of continued surveillance and molecular characterization of EPEC strains. The findings contribute to the development of targeted interventions to mitigate foodborne infections and improve public health.

1. Introduction

A 40% reduction in the global average incidence of foodborne diarrhoeal diseases, calculated per 100,000 population, is one of the key indicators outlined in the World Health Organization (WHO) Global Strategy for Food Safety. This ambitious target, set for achievement by 2030, reflects a global commitment to improving public health by reducing the burden of foodborne diseases. The reduction analysis specifically considers the incidence of diarrhoeal diseases caused by five major pathogens: Shiga toxin-producing Escherichia coli (STEC), Campylobacter spp., Enteropathogenic E. coli (EPEC), Enterotoxigenic E. coli (ETEC), and Non-typhoidal Salmonella enterica. These pathogens were selected due to their significant contribution to the global burden of foodborne illness, as highlighted in the WHO’s 2021 report.
Enteropathogenic Escherichia coli (EPEC) is a significant diarrheagenic pathotype known for causing severe infant diarrheal outbreaks, particularly in developing countries where public health infrastructure may be limited [1,2]. EPEC infections are typically transmitted to humans through the consumption of contaminated food, often because of inadequate sanitation and hygiene practices in food production and handling [3]. This mode of transmission poses a substantial risk to public health, especially in regions prone to diarrheal disease outbreaks.
Enteropathogenic Escherichia coli (EPEC) has been isolated from a diverse array of food sources, including meat, seafood, vegetables, fruits, and dairy products, underscoring the widespread nature of its contamination potential [4,5,6,7,8]. Contaminated animal products represent a notable risk, given their frequent consumption, especially among vulnerable populations [9]. Animals, particularly livestock, can act as reservoirs for the EPEC, thereby facilitating transmission to humans. As a result, surveillance of EPEC in animal populations and animal-derived products becomes essential for public health risk mitigation.
Given EPEC’s pathogenicity and its health implications, there is a strong need for ongoing surveillance of its transmission pathways, virulence factors, and strains, as well as understanding the mechanisms by which these strains contribute to disease outbreaks. Such efforts are critical for developing effective prevention strategies and safeguarding public health from EPEC-related infections [10,11]. Upon attachment to the host intestinal epithelium, EPEC employs a type III secretion system (T3SS) to inject effector proteins into the host cells. The T3SS is known as a transport apparatus primarily used by Gram-negative bacteria to insert effector proteins into host cytoplasmic cells. This secretion system allows bacteria to manipulate host cellular processes, helping them establish infections, evade the immune response, and promote their own survival [12,13]. The effector proteins delivered by the T3SS can disrupt cellular signalling, induce inflammation, and facilitate bacterial entry into host cells [14].
Typical EPEC has the locus of enterocyte effacement (LEE) region, which is a 35.6 kb pathogenicity island that encodes the T3SS [15,16,17]. The LEE pathogenicity region is categorized into five gene clusters, named LEE1 to LEE5 [16], which harbour 41 genes that encode structural components of the T3SS, including six translocated effectors, regulators, and chaperones [13]. The esc genes found in the inner and outer membranes of the T3SS are encoded by the LEE1 to LEE3 gene clusters and contribute to the formation of the core structures of the system. The LEE4 consists of translocator proteins EspD and EspB, which are responsible for the assembly of the T3SS. The Tir effector is encoded by LEE5 [17]. Effector proteins encoded by the T3SS are found within and outside the LEE, alongside non-LEE effectors [12].
Non-LEE effector proteins play a significant role in enhancing inflammation and inducing cell death within the epithelium [12]. Non-LEE encoded T3SS effectors, such as Cif, NleA to NleH, EspL, EspJ, and EspO, perform distinct functions within the host cellular system to facilitate infection [17]. The presence of these non-LEE effector proteins varies among different EPEC serotypes, with some effectors being absent in certain strains [18].
The T3SS comprises diversified proteins with varied functions. For instance, escU, escV, escR, escT, and escS form the export apparatus, while escN, escL, and escO comprise the cytosolic ATPase complex. Additionally, the effector protein espA forms a filament, and espB and espD create the translocation pore. The assembly and translocation of effectors within the T3SS rely on these proteins [19]. Among the LEE-encoded proteins, escV contributes to the structural stability of the T3SS, escD forms part of the injectisome, allowing effectors to pass through, and escU is involved in the secretion of translocator proteins. Meanwhile, escN hydrolyzes ATP to provide the energy needed for effector secretion [20].
The export apparatus is assembled from five highly conserved membrane proteins: escR, escS, escT, escU, and escV. EscV consists of two large domains: a cytoplasmic domain at the C-terminal end and an N-terminal pathway with seven to eight transmembrane domains (TMDs). The recruitment of T3SS substrates, chaperones, and proteins from the “gatekeeper” family to the T3SS apparatus is linked to escV and its homologs in both pathogenic and flagellar T3SS [20,21,22,23]. EscD is a member of the single-span transmembrane proteins in the EscD/PrgH/YscD family, characterized by a larger C-terminal periplasmic domain and a smaller N-terminal cytoplasmic region [24,25,26].
The use of genome-based analysis has allowed analysis of various gene clusters within the pathogenic islands found in bacteria that are responsible for the assembly and functioning of the T3SS [27]. Structural prediction of the T3SS using in silico-based techniques, such as the Swiss-model, enables the construction of three-dimensional structures of proteins using their amino acid sequences; with these tools, comparative analysis of various proteins within the T3SS can be employed [28,29]. This study employed in silico genome-based approaches to predict the functional characteristics of T3SS structural proteins as well as core effector proteins found in EPEC strains isolated from food-producing animals and products of animal origin. The study specifically focused on core proteins, EscV and EscD only, as they play a major role in exporting proteins and formation of the basal body, while the EspA protein was selected due to its key role in the assembly of the filament and an effector protein that interacts directly with the host.

2. Materials and Methods

2.1. Bacterial Strains

A total of 27 previously identified EPEC strains [30] isolated from food-producing animals and products of animal origin in South Africa and imported meat products from North America and Europe were utilized in the current study (Table 1). These isolates were selected to represent a range of geographic regions, and the sample sources were selected to ensure that both hosts and environments where E. coli occurs are represented. DNA extraction, data pre-processing, and whole genome sequencing of the isolates were performed as previously described by Malesa and team [30].

2.2. Determination of LEE Effector Proteins

To screen for locus of enterocyte effacement (LEE), a query coverage of 85% and 95% identity was used as criteria for selecting T3SS genes for the study. DNA sequences were then analyzed using ORFFinder (https://www.ncbi.nlm.nih.gov/orffinder?tdsourcetag=s_pcqq_aiomsg, accessed on 10 September 2024) to confirm the presence of open reading frames.
The Virulence Factor Database (VFDB) [31] was used to identify the virulence factors associated with our isolates. Based on the VFDB results, various contigs were analyzed using MEGA v11 to pinpoint the locations where these genes were harboured. Nucleotide sequences of each contig were selected and translated into protein sequences using MEGA v11, focusing on a subset of conserved proteins included in the study, escV, escD, escU, escN, espA, espD, espG, and eae.

2.3. Functional Annotation of Proteins

Further analysis involved examining the protein sequences using the Simple Modular Architecture Research Tool (SMART) based on Hidden Markov Models to identify and annotate signalling domains [32]. The Genomic SMART mode (https://smart.embl.de/smart/change_mode.cgi, accessed on 10 September 2024) was employed for protein analysis in this study, with searches conducted using default settings. Conserved protein domains were verified through the NCBI Conserved Domain Database (CDD) [33], with input protein sequences processed under default conditions.

2.4. Validation of SMART

To assess sequence similarities for each protein, a BLASTp search was conducted for each protein sequence [32]. The query protein sequences were analyzed using default settings, with results considered valid if they exhibited a query coverage of 90% and a percentage identity exceeding 95%.

2.5. Analysis of Physiochemical Properties

To assess protein stability and composition, the physicochemical properties of each protein were determined using the ProtParam tool on Expasy (https://web.expasy.org/protparam/, accessed on 12 September 2024). Each protein sequence was analyzed under default parameters.

2.6. Protein–Protein Interactions

The STRING database (https://string-db.org/, accessed on 12 September 2024) was used to construct a network of interactions between distinct known and predicted proteins. The analysis was performed using a full STRING network, with network edges adjusted to confidence mode, a minimum interaction score of 0.4, and a maximum of 20 interactions.

2.7. Determination of Transmembrane Domains

Transmembrane domains (TMDs) were identified using the TMHMM v2.0 tool (https://services.healthtech.dtu.dk/services/TMHMM-2.0/, accessed on 12 September 2024) for predicting transmembrane protein helices, with confirmation of TMDs performed using the PHOBIUS tool (https://phobius.sbc.su.se/, accessed on 10 September 2024). The topology of the sequences was then determined using Protter (https://wlab.ethz.ch/protter/start/, accessed on 10 September 2024). For each tool, protein sequences were input and analyzed using default settings.

2.8. Protein Structure Prediction

Protein structures of the components of the T3SS were predicted using Swiss-Model (https://swissmodel.expasy.org/, accessed on 14 September 2024). The target sequence was submitted to the server, which automatically searched for templates that were selected based on sequence identity. Model quality was assessed using the Ramachandran plot and MolProbity server version 4.2. To enhance the robustness and reliability of the predictions, additional tools were employed. The SOPMA tool (https://npsa-prabi.ibcp.fr/cgi-bin/npsa_automat.pl?page=/NPSA/npsa_sopma.html, accessed on 14 September 2024) was used for accurate prediction of the secondary structure of each protein.

2.9. Multiple Sequence Alignment

Multiple sequence alignment of the three (escV, escD, espA) proteins analyzed in this study was aligned with homologous sequences retrieved from the NCBI database based on sequence similarities. The COBALT multiple alignment tool from NCBI was used for alignment (https://www.ncbi.nlm.nih.gov/tools/cobalt/re_cobalt.cgi, accessed on 29 September 2025) using default parameters. The alignment was visualized using the Jalview tool version 2.11.5 [34], 2004).

3. Results

3.1. Analysis of Virulence Genes

Upon analyzing the VFDB results, various genes encoding T3SS proteins were identified. Notably, only 3 isolates (SAMN41920865, SAMN41920868, and SAMN41920872) carried LEE proteins associated with T3SS structural properties (Table S1); however, proteins from LEE1 through LEE5 were detected.

3.2. Determination of Protein Domains

Several LEE-encoding T3SS proteins were analyzed using SMART and subsequently confirmed with the CDD tool. Genes with a significant impact on T3SS function were selected and categorized based on their roles. The detected proteins included those associated with structural formation, such as escV, escN, escD, and escU; core effector proteins related to pathogenicity, including espA, espD, and espB; and genes responsible for adhesion and attachment, such as eae (Table 2). According to the SMART analysis, fifteen protein domains related to the T3SS were identified, with the majority classified using the Protein Families Database (Pfam). Of the eleven proteins analyzed, the nleB1protein could not be linked to a specific protein domain. Each protein was associated with a single protein domain, except for the eae protein, which exhibited at least six distinct domains (Table 2).

3.3. Analysis of SMART Validation

The selected proteins showed high similarity to known E. coli proteins in the NCBI BLASTp database. Each protein analyzed displayed 100% query coverage and over 99% sequence identity with existing protein sequences (Table 3).

3.4. Physiochemical Properties of Encoded T3SS Proteins

Analysis of the LEE encoding proteins revealed significant variability in protein lengths. The proteins eae, escV, escN, and escD were among the longest (insert the length), while espA and escU were considerably shorter (insert the length). This variation in length correlated with molecular weight: eae, with 939 amino acids, had a molecular weight of 101,684.77 Da, whereas espA, with 192 amino acids, had a molecular weight of 20,534.02 Da. The Grand Average of Hydropathicity (GRAVY) results indicated that escU, escN, and espG are hydrophobic proteins, whereas eae, espA, espD, and escV are hydrophilic. The instability index further revealed that escU, escN, and eae are relatively stable proteins, with indices below 40, while espD and escV showed indices close to the instability threshold, but these proteins are still below 40 and are considered to be relatively stable (Table S2). All non-LEE encoding genes were associated with proteins classified as hydrophilic based on their GRAVY results. These proteins exhibited variability in length and molecular weight, but their aliphatic indices were similar, ranging from 82 to 88.

3.5. Analysis of Protein–Protein Interactions

Protein interactions were analyzed using the STRING database (Figure 1). All proteins studied showed high identity to the E. coli O157 strain (EDL933) with a taxonomic identifier of 155,864. The protein networks for both LEE and non-LEE proteins demonstrated that they are associated with other known bacterial secretion proteins. The T3SS complex was found to include proteins such as Flil, EprK, EprS, and EscJ. Proton-transporting ATPase activity is associated with Flil, EivC, and EscN. Most of these proteins are involved in biological processes such as protein secretion, protein transport, and other cellular functions. Specifically, the T3SS complex is present in EscC, EscJ, and EscN.

3.6. Analysis of Transmembrane Domains (TMD)

Transmembrane domains (TMDs) were analyzed using Phobius, and the structural topology was determined with Protter. The structural protein escV was found to have seven TMDs, escU had two TMDs, and escD had one TMD (Figure 2 and Figure S1). Additionally, N-glyco motifs were identified in these sequences, while signal peptides were absent. Analysis of the T3SS core effector proteins revealed that the espA protein had one TMD, and espD had three TMDs (Figure 3). Non-LEE proteins were found not to contain any TMDs.

3.7. Predicted Protein Structures

Three proteins were selected for three-dimensional structural analysis: escV and escD to represent structural proteins and espA to represent core effector proteins (Figure 4 and Figure 5). Based on sequence identity, coverage, and Ramachandran plot analysis, the most appropriate models were chosen. The template selected for escV was A0A3I8FV28.1A, which showed a sequence identity of 78.22% to the EscV/YscV/HrcV family T3SS export apparatus protein, and the structure consisted of a single subunit (monomer). The selected model for espA was 7khw.1.J, a translocon protein with 88.54% sequence identity, featuring an oligomeric state of homo-50-mer. For the escD protein, the most appropriate template selected was B1EHF2.1.A, which had 95.07% sequence identity.

3.8. Quality Assessment of 3D-Structures

The Ramachandran plot quality assessment for the escV and espA proteins yielded MolProbity scores of 1.38 and 1.35, respectively. The majority of residues observed in the Ramachandran plot were well-folded, with 96.14% of residues for escV and 92.36% for espA (Table 4).

3.9. Secondary Structure of the Proteins

The analysis of the secondary structure of the proteins in terms of alpha-helix, beta-sheet, and coil states (Table 5) was conducted. Protein escV, consisting of 675 amino acids, exhibited 52.59% alpha-helix, 17.48% extended strand, 5.48% beta-turn, and 24.44% random coil. Protein espA, with 192 amino acids, had 68.75% in alpha-helix, 2.08% in extended strand, no beta-turn, and 29.17% in random coil.

3.10. Conservation of Proteins

Sequence alignment revealed high conservation across protein sequences included in this study. Conserved motifs were observed in various positions 430–490 (Figure S2). The C-terminal region also exhibited conserved segments, which indicates structural stability.

4. Discussion

To thoroughly analyze the various components of the type three secretion system detected in EPEC strains in South Africa, EscV, EscD, and EspA were intentionally selected. The EscV protein was selected to represent the inner membrane export apparatus, the EscD protein for its importance in maintaining the structure of the system, and EspA as the needle component, which is the extracellular filament of the system [35].
Enteropathogenic E. coli is one of the most important causes of diarrhoeal disease in both humans and animals, often resulting in high mortality rates in children, especially in developing countries [36]. Typical EPEC strains often consist of the locus of enterocyte effacement (LEE), which is a region used for attaching and effacing to colonize the host’s intestines. This region encodes for the T3SS [37]. This study was carried out to predict the structural and functional characteristics of the T3SS in EPEC strains using various in silico techniques. To the best of our knowledge, in South Africa, there is currently no published data that investigates the T3SS in EPEC strains.
In other countries, the occurrence of the T3SS has been identified in EPEC strains from various sources, and these isolates have been found to possess various virulence genes that are crucial for EPEC’s pathogenicity. In African countries, there are very few studies that are sequenced, which are focused on characterizing EPEC strains. In a study conducted in Nigeria, it was found that one EPEC isolate contained a hemolysin gene, ehx, which is commonly found in EHEC pathotypes, and the presence of non-LEE genes was also detected [38].
A study was conducted in 2023, which analyzed three diarrheagenic E. coli pathotypes (EAEC, EPEC, and STEC) in three African countries, Gambia, Kenya, and Mali, over a period of three years. This study highlighted atypical EPEC as the second most common pathotype to occur, which often results in high mortalities [39]. In Zambia, Kenya, Mozambique, Rwanda, and Sudan, EPEC has been reported as the most prevalent pathotype [40,41,42].
Moreover, a systematic review of E. coli virulence and antibiotic resistance profiles in various African countries revealed that in Africa, antibiotics are abused, and this has led to widespread resistance. Also, virulence determinants of E. coli, such as eae, stx1, stx2, ast, fliC07, papC, and eagg virulence genes have been found to occur across various E. coli matrices. This observation was found to be evident in South Africa and Nigeria, as they tend to test E. coli on various matrices [43].
Protein domains play a crucial role in the functioning of the Type III Secretion System (T3SS). The flagellum/hypersensitive response/invasion protein export pore (FHIPEP) domain, which is part of the conserved export protein domains, has not been fully characterized, but it is thought to play a role in sorting substrates into the pore of the export apparatus to aid in the delivery of effector proteins [44]. In proteobacteria, the Yop-YscD_ppl domain is part of the periplasmic domain of Yop proteins and forms part of the inner membrane of the injectisome [45]. Bacterial transmembrane domains, which are essential for bacteria to move along host cellular membranes, contain proteins that target the host, playing a key role in infection [46].
The effector proteins encoded by the Locus of Enterocyte Effacement (LEE) pathogenicity island in T3SS include espF, espG, espH, espZ, and map, along with translocator proteins espA, espB, and espD [47,48]. As one of the largest export apparatus proteins, escV, is responsible for controlling the export gate of the T3SS, while escD forms part of the inner membrane of the basal body and plays a critical role in secretion regulation within the inner membrane [49]. Additionally, the ATPase activity of escN drives its interactions with T3SS effectors and chaperones [50].
EscV consists of 675 amino acids and has a molecular weight of 75,150.08 Da, while escD has 406 amino acids and a molecular weight of 45,316.26 Da. The aliphatic index, calculated based on the percentage of alanine, valine, isoleucine, and leucine, was high for both proteins, indicating increased thermostability. Both proteins were also determined to be stable, with instability index values below 40 (escV 39.61, escD 39.83), suggesting they are less prone to denaturation under physiological conditions [51].
The theoretical isoelectric point (pI) of the proteins ranged from 4 to 10, suggesting electrical neutrality under normal conditions. The Grand Average of Hydropathicity (GRAVY) for escV was positive (0.355), indicating hydrophobic characteristics, while escD had a negative GRAVY value (−0.087), suggesting it contains hydrophilic amino acids [52]. Though hydrophobicity is only one factor, it plays a key role in understanding protein solubility and interactions [53].
Protein interactions for escV and escD were analyzed using the STRING database, with E. coli O157 EDL933, a highly pathogenic strain, selected as a reference. The escV protein shared 97.9% identity with the reference strain, while escD shared 96.8%. Both proteins were found to interact with other related T3SS proteins such as escT, escR, escS, and escU, which form part of the conserved export apparatus between the flagellar system and the injectisome [14,54]. EscV forms a pore in the inner membrane through which effectors are translocated, while escD is part of the base structure of the injectisome, interacting with escC and escJ proteins to maintain its structural integrity [14].
The conserved domains of these proteins were identified using the Conserved Domain Database (CDD), while the transmembrane domains (TMD) were predicted with TMHMM v2.0. EscV was found to have seven TMDs, each with varying residues. This protein plays a critical role in recruiting T3SS chaperones, substrates, and other proteins, facilitating the assembly and function of the T3SS [20]. Both proteins’ 3D models were validated using Ramachandran plots, with over 90% of the residues falling within favoured regions, indicating high model quality [55]. The MolProbity score for these structures was <1.8, further confirming their reliability [56].
Secondary structures, including beta strands, beta turns, alpha helices, and random coils, were predicted using the SOPMA tool. These structural elements are crucial for protein stability, serving as binding sites for other molecules and influencing protein function [57]. This detailed characterization of escV and escD enhances our understanding of their role in the T3SS and provides insights into the molecular mechanisms governing their function.
The T3SS comprises various components with diverse functions; these include causing cell death, disrupting the host cytoskeleton, and manipulating cellular activities. Several studies have developed strategies to inhibit activities of the T3SS; some of these include suppressing activities of some effector proteins, which then results in the system being less virulent [35]. For EPEC and EHEC infections, a mouse model using Citrobacter rodentium was developed to inhibit the effector protein responsible for adhesion of the T3SS. Although other effector proteins were not inhibited and released into the host, this resulted in minimal infections [35,58]. Studies focused on therapeutics have targeted the use of T3SS since some of the structural and functional characteristics of this system are able to facilitate designs of antibiotics that are mechanism-based; such studies are required to overcome antibiotic resistance [58].
Other inhibitors of the T3SS include the use of chemical compounds such as 2-imino-5-arylidene thiazolidinone, which blocked the system as well as its virulence functions [59,60]. The first ever natural inhibitor used for T3SS was glycolipid caminoside A, which was able to reduce the secretion of EPEC. A compound in body fluids, lactoferrin, was also targeted at the T3SS virulence mechanisms. The disadvantage with some of these natural compounds is their toxicity to eukaryotic cells [60].
Sequence alignment of proteins included in this study showed a high conservation in comparison to other E. coli EPEC strains, which contain the same proteins. Apparatus such as the escV and escD in the T3SS structure are known to be well conserved [20]. The espA protein remains conserved due to its helical assembly [61].

5. Conclusions

The present study focused on the functional characterization of EPEC strains, specifically investigating the structural and core effector proteins associated with the Type III Secretion System (T3SS) using in silico; therefore, no experimental techniques were employed for this analysis. The findings revealed that the isolates with a functional T3SS identified in this study belong to the EPEC pathotype. Notably, the presence of the Locus of Enterocyte Effacement (LEE) pathogenic island underscores the virulence of these strains, affirming their pathogenic potential. The high-resolution structural analysis, along with robust validation data, indicates that the proteins in question are stable and likely to maintain their functional integrity.
Though there was a lack of experimental studies conducted for this analysis, to the best of our knowledge, this is the first report documenting EPEC strains harbouring a functional T3SS in South Africa. This highlights the importance of continued surveillance and characterization of pathogenic E. coli strains within the region. Future research should involve a larger sample size, and experimental validations should be carried out to further support these predictions and to better understand the distribution and epidemiology of EPEC pathotypes carrying functional secretion systems across the country. Expanding the scope of study to include different regions and environmental sources would provide a more comprehensive picture of the pathogenic landscape and contribute to the development of targeted public health interventions.

Supplementary Materials

The following supporting information can be downloaded at: https://www.mdpi.com/article/10.3390/pathogens14111099/s1, Table S1: Detected LEE proteins and their grouping. Table S2: Physiochemical properties of LEE encoded proteins. Figure S1: Predicted transmembrane protein domains of LEE and non-LEE genes using Phobius. Figure S2: Multiple sequence alignment of T3SS proteins (espA, escD, escV). The ClustaW scheme was used for colouring residues in this alignment.

Author Contributions

R.M., I.M. and R.P.: conceptualization. I.M. and R.P.: supervision. R.M.: preparation and writing of original draft, methodology, and bioinformatics analysis. I.M., R.P., K.M., E.S. and T.M.: review and editing of manuscript. I.M.: sourced the funding and supervised the project. All authors have read and agreed to the published version of the manuscript.

Funding

This research was funded by the Gauteng department of Agriculture and Rural development (Project number P10000152). The views expressed by the authors do not necessarily reflect those of the funders.

Institutional Review Board Statement

Ethics approval was obtained from the University of South Africa, Department of Life and Consumer Sciences Research Ethics Committee (2023/CAES_HREC/010). The University of South Africa approved the methods that are used in this study in accordance with the relevant guidelines and regulations.

Data Availability Statement

The Dataset in this study is available in the NCBI Sequence Read Archive repository with accession number: PRJNA1126085.

Acknowledgments

The authors wish to acknowledge the Agricultural Research Council-Onderstepoort Veterinary Research Feed and Food laboratory staff who processed the samples.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Shen, J.; Zhi, S.; Guo, D.; Jiang, Y.; Xu, X.; Zhao, L.; Lv, J. Prevalence, antimicrobial resistance, and whole genome sequencing analysis of shiga toxin-producing Escherichia coli (STEC) and enteropathogenic Escherichia coli (EPEC) from imported foods in China during 2015–2021. Toxins 2022, 14, 68. [Google Scholar] [CrossRef]
  2. Lee, W.; Sung, S.; Ha, J.; Kim, E.; An, E.S.; Kim, S.H.; Kim, S.H.; Kim, H.Y. Molecular and genomic analysis of the virulence factors and potential transmission of hybrid enteropathogenic and enterotoxigenic Escherichia coli (EPEC/ETEC) strains isolated in South Korea. Int. J. Mol. Sci. 2023, 24, 12729. [Google Scholar] [CrossRef]
  3. Luna-Guevara, J.; Arenas-Hernandez, M.M.; Martínez de la Peña, C.; Silva, J.L.; Luna-Guevara, M.L. The role of pathogenic E. coli in fresh vegetables: Behavior, contamination factors, and preventive measures. Int. J. Microbiol. 2019, 2019, 2894328. [Google Scholar] [CrossRef]
  4. Lindberg, A.M.; Ljungh, Å.; Ahrne, S.; Löfdahl, S.; Molin, G. Enterobacteriaceae found in high numbers in fish, minced meat and pasteurised milk or cream and the presence of toxin encoding genes. Int. J. Food Microbiol. 1998, 39, 11–17. [Google Scholar] [CrossRef]
  5. Nataro, J.P.; Kaper, J.B. Diarrheagenic Escherichia coli. Clin. Microbiol. Rev. 1998, 11, 142–201. [Google Scholar] [CrossRef] [PubMed]
  6. Norazah, A.; Rahizan, I.; Zainuldin, T.; Rohani, M.Y.; Kamel, A.G.M. Enteropathogenic Escherichia coli in raw and cooked food. Southeast Asian J. Trop. Med. Public Health 1998, 29, 91–93. [Google Scholar] [PubMed]
  7. da Silva, Z.N.; da Cunha, A.S.; Lins, M.C.; Carneiro, L.D.A.; Almeida, A.C.D.F.; Queiroz, M.L. Isolation and serological identification of enteropathogenic Escherichia coli in pasteurized milk in Brazil. Rev. Saude Publica 2001, 35, 375–379. [Google Scholar] [CrossRef]
  8. Araújo, V.S.; Pagliares, V.A.; Queiroz, M.L.P.; Freitas-Almeida, A.C. Occurrence of Staphylococcus and enteropathogens in soft cheese commercialized in the city of Rio de Janeiro, Brazil. J. Appl. Microbiol. 2002, 92, 1172–1177. [Google Scholar] [CrossRef]
  9. Bloomfield, S.F.; Aiello, A.E.; Cookson, B.; O’Boyle, C.; Larson, E.L. The effectiveness of hand hygiene procedures in reducing the risks of infections in home and community settings including handwashing and alcohol-based hand sanitizers. Am. J. Infect. Control. 2007, 35, S27–S64. [Google Scholar] [CrossRef]
  10. Ramos, S.; Silva, V.; Dapkevicius, M.D.L.E.; Caniça, M.; Tejedor-Junco, M.T.; Igrejas, G.; Poeta, P. Escherichia coli as commensal and pathogenic bacteria among food-producing animals: Health implications of extended spectrum β-lactamase (ESBL) production. Animals 2020, 10, 2239. [Google Scholar] [CrossRef] [PubMed]
  11. Abdalla, S.E.; Abia, A.L.; Amoako, D.G.; Perrett, K.; Bester, L.A.; Essack, S.Y. Food animals as reservoirs and potential sources of multidrug-resistant diarrheagenic E. coli pathotypes: Focus on intensive pig farming in South Africa. Onderstepoort J. Vet. Res. 2022, 89, 1963. [Google Scholar] [CrossRef] [PubMed]
  12. Cepeda-Molero, M.; Schüller, S.; Frankel, G.; Fernández, L.Á.; Cepeda-Molero, M.; Schüller, S.; Fernández, L.Á. Systematic deletion of type III secretion system effectors in Enteropathogenic E. coli unveils the role of non-LEE effectors in a/E lesion formation. In E. coli Infections-Importance of Early Diagnosis and Efficient Treatment; IntechOpen: Rijeka, Croatia, 2020. [Google Scholar]
  13. Serapio-Palacios, A.; Finlay, B.B. Dynamics of expression, secretion and translocation of type III effectors during enteropathogenic Escherichia coli infection. Curr. Opin. Microbiol. 2020, 54, 67–76. [Google Scholar] [CrossRef]
  14. Wagner, S.; Grin, I.; Malmsheimer, S.; Singh, N.; Torres-Vargas, C.E.; Westerhausen, S. Bacterial type III secretion systems: A complex device for the delivery of bacterial effector proteins into eukaryotic host cells. FEMS Microbiol. Lett. 2018, 365, fny201. [Google Scholar] [CrossRef]
  15. Elliott, S.J.; Sperandio, V.; Girón, J.A.; Shin, S.; Mellies, J.L.; Wainwright, L.; Hutcheson, S.W.; McDaniel, T.K.; Kaper, J.B. The locus of enterocyte effacement (LEE)-encoded regulator controls expression of both LEE-and non-LEE-encoded virulence factors in enteropathogenic and enterohemorrhagic Escherichia coli. Infect. Immun. 2000, 68, 6115–6126. [Google Scholar] [CrossRef]
  16. Franzin, F.M.; Sircili, M.P. Locus of enterocyte effacement: A pathogenicity island involved in the virulence of enteropathogenic and enterohemorragic Escherichia coli subjected to a complex network of gene regulation. BioMed Res. Int. 2015, 2015, 534738. [Google Scholar] [CrossRef]
  17. Tejeda-Dominguez, F.; Huerta-Cantillo, J.; Chavez-Dueñas, L.; Navarro-Garcia, F. A novel mechanism for protein delivery by the type 3 secretion system for extracellularly secreted proteins. mBio 2017, 8, e00184-17. [Google Scholar] [CrossRef]
  18. Santos, A.S.; Finlay, B.B. Bringing down the host: Enteropathogenic and enterohaemorrhagic Escherichia coli effector-mediated subversion of host innate immune pathways. Cell. Microbiol. 2015, 17, 318–332. [Google Scholar] [CrossRef]
  19. Díaz-Guerrero, M.; Gaytán, M.O.; Soto, E.; Espinosa, N.; García-Gómez, E.; Marcos-Vilchis, A.; Andrade, A.; González-Pedrajo, B. CesL regulates type III secretion substrate specificity of the enteropathogenic E. coli injectisome. Microorganisms 2021, 9, 1047. [Google Scholar] [CrossRef]
  20. Mitrović, B.; Lezerovich, S.; Sal-Man, N. The role of the membrane-associated domain of the export apparatus protein, EscV (SctV), in the activity of the type III secretion system. Front. Microbiol. 2021, 12, 719469. [Google Scholar] [CrossRef] [PubMed]
  21. Portaliou, A.G.; Tsolis, K.C.; Loos, M.S.; Balabanidou, V.; Rayo, J.; Tsirigotaki, A.; Crepin, V.F.; Frankel, G.; Kalodimos, C.G.; Karamanou, S.; et al. Hierarchical protein targeting and secretion is controlled by an affinity switch in the type III secretion system of enteropathogenic Escherichia coli. EMBO J. 2017, 36, 3517–3531. [Google Scholar] [CrossRef] [PubMed]
  22. Kuhlen, L.; Abrusci, P.; Johnson, S.; Gault, J.; Deme, J.; Caesar, J.; Dietsche, T.; Mebrhatu, M.T.; Ganief, T.; Macek, B.; et al. Structure of the core of the type III secretion system export apparatus. Nat. Struct. Mol. Biol. 2018, 25, 583–590. [Google Scholar] [CrossRef]
  23. Wagner, S.; Diepold, A. A unified nomenclature for injectisome-type type III secretion systems. In Bacterial Type III Protein Secretion Systems; Springer: Berlin/Heidelberg, Germany, 2020; pp. 1–10. [Google Scholar]
  24. Deng, W.; Puente, J.L.; Gruenheid, S.; Li, Y.; Vallance, B.A.; Vázquez, A.; Barba, J.; Ibarra, J.A.; O’Donnell, P.; Metalnikov, P.; et al. Dissecting virulence: Systematic and functional analyses of a pathogenicity island. Proc. Natl. Acad. Sci. USA 2004, 101, 3597–3602. [Google Scholar] [CrossRef] [PubMed]
  25. Ogino, T.; Ohno, R.; Sekiya, K.; Kuwae, A.; Matsuzawa, T.; Nonaka, T.; Fukuda, H.; Imajoh-Ohmi, S.; Abe, A. Assembly of the type III secretion apparatus of enteropathogenic Escherichia coli. J. Bacteriol. 2006, 188, 2801–2811. [Google Scholar] [PubMed]
  26. Tseytin, I.; Dagan, A.; Oren, S.; Sal-Man, N. The role of EscD in supporting EscC polymerization in the type III secretion system of enteropathogenic Escherichia coli. Biochim. Biophys. Acta (BBA)-Biomembr. 2018, 1860, 384–395. [Google Scholar] [CrossRef]
  27. Zakaria, D.; Matsuda, S.; Iida, T.; Hayashi, T.; Arita, M. Genome Analysis Identifies a Novel Type III Secretion System (T3SS) Category in Vibrio Species. Microorganisms 2023, 11, 290. [Google Scholar] [CrossRef] [PubMed]
  28. Arnold, K.; Bordoli, L.; Kopp, J.; Schwede, T. The SWISS-MODEL workspace: A web-based environment for protein structure homology modelling. Bioinformatics 2006, 22, 195–201. [Google Scholar] [CrossRef]
  29. Katz, A.; Porte, L.; Weitzel, T.; Varela, C.; Muñoz-Rehbein, C.; Ugalde, J.A.; Grim, C.; González-Escalona, N.; Blondel, C.J.; Bravo, V. Whole-genome sequencing reveals changes in genomic diversity and distinctive repertoires of T3SS and T6SS effector candidates in Chilean clinical Campylobacter strains. Front. Cell. Infect. Microbiol. 2023, 13, 1208825. [Google Scholar] [CrossRef]
  30. Malesa, R.; Pierneef, R.; Magwedere, K.; Mafuna, T.; Matle, I. Genomic characterisation of generic Escherichia coli from food-producing animals and products of animal origin in South Africa. Front. Bacteriol. 2024, 3, 1432292. [Google Scholar] [CrossRef]
  31. Chen, L.; Zheng, D.; Liu, B.; Yang, J.; Jin, Q. VFDB 2016: Hierarchical and refined dataset for big data analysis—10 years on. Nucleic Acids Res. 2016, 44, D694–D697. [Google Scholar] [CrossRef]
  32. Schultz, J.; Milpetz, F.; Bork, P.; Ponting, C.P. SMART, a simple modular architecture research tool: Identification of signaling domains. Proc. Natl. Acad. Sci. USA 1998, 95, 5857–5864. [Google Scholar] [CrossRef]
  33. Wang, J.; Chitsaz, F.; Derbyshire, M.K.; Gonzales, N.R.; Gwadz, M.; Lu, S.; Marchler, G.H.; Song, J.S.; Thanki, N.; Yamashita, R.A.; et al. The conserved domain database in 2023. Nucleic Acids Res. 2023, 51, D384–D388. [Google Scholar] [CrossRef]
  34. Clamp, M.; Cuff, J.; Searle, S.M.; Barton, G.J. The jalview java alignment editor. Bioinformatics 2004, 20, 426–427. [Google Scholar] [CrossRef] [PubMed]
  35. Hotinger, J.; Pendergrass, H.A.; May, A.E. Molecular targets and strategies for inhibition of the bacterial type III secretion system (T3SS); inhibitors directly binding to T3SS components. Biomolecules 2021, 11, 316. [Google Scholar] [CrossRef] [PubMed]
  36. Bolukaoto, J.Y.; Singh, A.; Alfinete, N.; Barnard, T.G. Occurrence of hybrid diarrhoeagenic Escherichia coli associated with multidrug resistance in environmental water, Johannesburg, South Africa. Microorganisms 2021, 9, 2163. [Google Scholar] [CrossRef]
  37. Whelan, R.; McVicker, G.; Leo, J.C. Staying out or going in? The interplay between type 3 and type 5 secretion systems in adhesion and invasion of enterobacterial pathogens. Int. J. Mol. Sci. 2020, 21, 4102. [Google Scholar] [CrossRef]
  38. Akinlabi, O.C.; Dada, R.A.; Olayinka, A.A.; Oginni-Falajiki, I.O.; Bejide, O.S.; Adewole, P.D.; Thomson, N.R.; Aboderin, A.O.; Okeke, I.N. Genomic epidemiology of enteropathogenic Escherichia coli in southwestern Nigeria. PLoS Neglected Trop. Dis. 2025, 19, e0013442. [Google Scholar] [CrossRef]
  39. Ochieng, J.B.; Powell, H.; Sugerman, C.E.; Omore, R.; Ogwel, B.; Juma, J.; Awuor, A.O.; Sow, S.O.; Sanogo, D.; Onwuchekwa, U.; et al. Epidemiology of Enteroaggregative, Enteropathogenic, and Shiga Toxin–Producing Escherichia coli among children aged <5 years in 3 countries in Africa, 2015–2018: Vaccine impact on Diarrhea in Africa (VIDA) Study. Clin. Infect. Dis. 2023, 76 (Supp. S1), S77–S86. [Google Scholar] [CrossRef]
  40. Saeed, A.; Abd, H.; Sandstrom, G. Microbial aetiology of acute diarrhoea in children under five years of age in Khartoum, Sudan. J. Med. Microbiol. 2015, 64, 432–437. [Google Scholar] [CrossRef] [PubMed]
  41. Webale, M.K.; Guyah, B.; Wanjala, C.; Nyanga, P.L.; Webale, S.K.; Abonyo, C.; Kitungulu, N.; Kiboi, N.; Bowen, N. Phenotypic and genotypic antibiotic resistant diarrheagenic Escherichia coli pathotypes isolated from children with diarrhea in Nairobi City, Kenya. Ethiop. J. Health Sci. 2020, 30, 881–890. [Google Scholar]
  42. Mwape, K.; Bosomprah, S.; Chibesa, K.; Silwamba, S.; Luchen, C.C.; Sukwa, N.; Mubanga, C.; Phiri, B.; Chibuye, M.; Liswaniso, F.; et al. Prevalence of diarrhoeagenic Escherichia coli among children aged between 0–36 months in peri-urban areas of Lusaka. Microorganisms 2023, 11, 2790. [Google Scholar] [CrossRef]
  43. Hounkpe, E.C.; Sessou, P.; Farougou, S.; Daube, G.; Delcenserie, V.; Azokpota, P.; Korsak, N. Prevalence, antibiotic resistance, and virulence gene profile of Escherichia coli strains shared between food and other sources in Africa: A systematic review. Vet. World 2023, 16, 2016. [Google Scholar] [CrossRef]
  44. Barker, C.S.; Inoue, T.; Meshcheryakova, I.V.; Kitanobo, S.; Samatey, F.A. Function of the conserved FHIPEP domain of the flagellar type III export apparatus, protein FlhA. Mol. Microbiol. 2016, 100, 278–288. [Google Scholar] [CrossRef]
  45. Kuebutornye, F.K.A.; Liao, J.; Pang, H.; Lu, Y.; Ayiku, S.; Sakyi, M.E. Molecular cloning and bioinformatics analysis of t3ss inner membrane ring hrpq from Vibrio harveyi. Genom. Appl. Biol. 2018, 9, 40–47. [Google Scholar] [CrossRef]
  46. Gershberg, J.; Braverman, D.; Sal-Man, N. Transmembrane domains of type III-secreted proteins affect bacterial-host interactions in enteropathogenic E. coli. Virulence 2021, 12, 902–917. [Google Scholar] [CrossRef] [PubMed]
  47. Mainil, J. Escherichia coli virulence factors. Vet. Immunol. Immunopathol. 2013, 152, 2–12. [Google Scholar] [CrossRef] [PubMed]
  48. Xu, Y.; Bai, X.; Jin, Y.; Hu, B.; Wang, H.; Sun, H.; Fan, R.; Fu, S.; Xiong, Y. High prevalence of virulence genes in specific genotypes of atypical enteropathogenic Escherichia coli. Front. Cell. Infect. Microbiol. 2017, 7, 109. [Google Scholar] [CrossRef]
  49. Worrall, L.J.; Bergeron, J.R.; Strynadka, N.C. Type 3 secretion systems. In Escherichia coli; Academic Press: Cambridge, MA, USA, 2013; pp. 417–450. [Google Scholar]
  50. Sirisaengtaksin, N.; O’Donoghue, E.J.; Jabbari, S.; Roe, A.J.; Krachler, A.M. Bacterial outer membrane vesicles provide an alternative pathway for trafficking of Escherichia coli O157 type III secreted effectors to epithelial cells. Msphere 2023, 8, e00520-23. [Google Scholar] [CrossRef] [PubMed]
  51. Guruprasad, K.; Reddy, B.B.; Pandit, M.W. Correlation between stability of a protein and its dipeptide composition: A novel approach for predicting in vivo stability of a protein from its primary sequence. Protein Eng. Des. Sel. 1990, 4, 155–161. [Google Scholar] [CrossRef]
  52. Kyte, J.; Doolittle, R.F. A simple method for displaying the hydropathic character of a protein. J. Mol. Biol. 1982, 157, 105–132. [Google Scholar] [CrossRef]
  53. Yarabbi, H.; Mortazavi, S.A.; Yavarmanesh, M.; Javadmanesh, A. In silico study of different signal peptides to express recombinant glutamate decarboxylase in the outer membrane of Escherichia coli. Int. J. Pept. Res. Ther. 2020, 26, 1879–1891. [Google Scholar] [CrossRef]
  54. Wagner, S.; Königsmaier, L.; Lara-Tejero, M.; Lefebre, M.; Marlovits, T.C.; Galán, J.E. Organization and coordinated assembly of the type III secretion export apparatus. Proc. Natl. Acad. Sci. USA 2010, 107, 17745–17750. [Google Scholar] [CrossRef] [PubMed]
  55. Nazarian, S.; Gargari, S.L.M.; Rasooli, I.; Amani, J.; Bagheri, S.; Alerasool, M. An in silico chimeric multi subunit vaccine targeting virulence factors of enterotoxigenic Escherichia coli (ETEC) with its bacterial inbuilt adjuvant. J. Microbiol. Methods 2012, 90, 36–45. [Google Scholar] [CrossRef] [PubMed]
  56. Cardoso, M.H.; Candido, E.S.; Chan, L.Y.; Der Torossian Torres, M.; Oshiro, K.G.; Rezende, S.B.; Porto, W.F.; Lu, T.K.; de la Fuente-Nunez, C.; Craik, D.J.; et al. A computationally designed peptide derived from Escherichia coli as a potential drug template for antibacterial and antibiofilm therapies. ACS Infect. Dis. 2018, 4, 1727–1736. [Google Scholar] [CrossRef] [PubMed]
  57. Angamuthu, K.; Piramanayagam, S. Evaluation of in silico protein secondary structure prediction methods by employing statistical techniques. Biomed. Biotechnol. Res. J. (BBRJ) 2017, 1, 29–36. [Google Scholar] [CrossRef]
  58. Deng, W.; Marshall, N.C.; Rowland, J.L.; McCoy, J.M.; Worrall, L.J.; Santos, A.S.; Strynadka, N.C.; Finlay, B.B. Assembly, structure, function and regulation of type III secretion systems. Nat. Rev. Microbiol. 2017, 15, 323–337. [Google Scholar] [CrossRef]
  59. Felise, H.B.; Nguyen, H.V.; Pfuetzner, R.A.; Barry, K.C.; Jackson, S.R.; Blanc, M.P.; Bronstein, P.A.; Kline, T.; Miller, S.I. An inhibitor of gram-negative bacterial virulence protein secretion. Cell Host Microbe 2008, 4, 325–336. [Google Scholar] [CrossRef]
  60. Blasey, N.; Rehrmann, D.; Riebisch, A.K.; Mühlen, S. Targeting bacterial pathogenesis by inhibiting virulence-associated Type III and Type IV secretion systems. Front. Cell. Infect. Microbiol. 2023, 12, 1065561. [Google Scholar] [CrossRef]
  61. Zheng, W.; Peña, A.; Ilangovan, A.; Baghshomali, Y.N.; Frankel, G.; Egelman, E.H.; Costa, T.R. Cryoelectron-microscopy structure of the enteropathogenic Escherichia coli type III secretion system EspA filament. Proc. Natl. Acad. Sci. USA 2021, 118, e2022826118. [Google Scholar] [CrossRef]
Figure 1. Protein–protein interaction network was generated using the STRING database. (A) represents the escV, escN proteins, (B) represents the escD, escU, espA, espD, (C) represents the non-LEE proteins, nleE, nleB1, nleG. The grey and yellow lines in between the nodes represent the interactions between proteins.
Figure 1. Protein–protein interaction network was generated using the STRING database. (A) represents the escV, escN proteins, (B) represents the escD, escU, espA, espD, (C) represents the non-LEE proteins, nleE, nleB1, nleG. The grey and yellow lines in between the nodes represent the interactions between proteins.
Pathogens 14 01099 g001
Figure 2. Predicted topology of T3SS proteins that are composed of transmembrane domains, structure determined using Protter. Structural protein escV consists of seven (1–7) TMDs, protein escD consists of one (8) TMD, protein escU consists of two (9–10). Inner membrane approximated with an orange rectangle. Letter N in green represents the N-glyco-motif sequences.
Figure 2. Predicted topology of T3SS proteins that are composed of transmembrane domains, structure determined using Protter. Structural protein escV consists of seven (1–7) TMDs, protein escD consists of one (8) TMD, protein escU consists of two (9–10). Inner membrane approximated with an orange rectangle. Letter N in green represents the N-glyco-motif sequences.
Pathogens 14 01099 g002
Figure 3. Predicted topology of T3SS Core effector protein espA, consisting of one (1) TMD and protein espD, consisting of three (2–4) TMDs. Inner membrane approximated with an orange rectangle. Letter N in green represents the N-glyco-motif sequences.
Figure 3. Predicted topology of T3SS Core effector protein espA, consisting of one (1) TMD and protein espD, consisting of three (2–4) TMDs. Inner membrane approximated with an orange rectangle. Letter N in green represents the N-glyco-motif sequences.
Pathogens 14 01099 g003
Figure 4. Three-dimensional structure of proteins and their Ramachandran plots, (A) escV protein, 96.14% of amino acids are on the favoured region (beta-sheet), 1.19% amino acids are outliers in this region; (B) espA protein with 92.36% amino acid residues on the favoured region, with 0.64% outliers.
Figure 4. Three-dimensional structure of proteins and their Ramachandran plots, (A) escV protein, 96.14% of amino acids are on the favoured region (beta-sheet), 1.19% amino acids are outliers in this region; (B) espA protein with 92.36% amino acid residues on the favoured region, with 0.64% outliers.
Pathogens 14 01099 g004
Figure 5. Three-dimensional structure of protein escD and its Ramachandran plot, 94.9% of amino acids are in the favoured region (beta-sheet), while 1.81% amino acids are outliers.
Figure 5. Three-dimensional structure of protein escD and its Ramachandran plot, 94.9% of amino acids are in the favoured region (beta-sheet), while 1.81% amino acids are outliers.
Pathogens 14 01099 g005
Table 1. Metadata of EPEC strains used in this study (n = 27).
Table 1. Metadata of EPEC strains used in this study (n = 27).
Accession
No.
Geographic
Location
RegionSource of
Isolation
SAMN41920845North AmericaNorth AmericaRaw poultry
SAMN41920846South AfricaMpumalangaRaw poultry
SAMN41920847NetherlandsEurope Raw poultry
SAMN41920848South AfricaFree StateRaw poultry
SAMN41920849South AfricaFree StateRaw poultry
SAMN41920851South AfricaFree StateRaw poultry
SAMN41920852South AfricaFree StateRaw poultry
SAMN41920853South AfricaFree StateRaw poultry
SAMN41920854South AfricaFree StateRaw poultry
SAMN41920855South AfricaFree StateProcessed pork
SAMN41920856South AfricaFree StateRaw lamb
SAMN41920858South AfricaFree StateRaw pork
SAMN41920860South AfricaFree StateRaw poultry
SAMN41920861South AfricaGautengDigestive system
SAMN41920862South AfricaGautengProcessed beef
SAMN41920863South AfricaGautengDigestive system
SAMN41920865South AfricaGautengDigestive system
SAMN41920867South AfricaGautengDigestive system
SAMN41920868South AfricaGautengDigestive system
SAMN41920869South AfricaGautengDigestive system
SAMN41920870EuropeEuropeRaw poultry
SAMN41920871South AfricaGautengDigestive system
SAMN41920872South AfricaGautengDigestive system
SAMN41920873South AfricaGautengDigestive system
SAMN41920876South AfricaGautengWater
SAMN41920877South AfricaLimpopoRTE beef
SAMN41920878South AfricaGautengDigestive system
Processed pork (Commercially processed pork meat), Digestive system (faecal material), and RTE (Ready-to-eat products).
Table 2. Summary of protein domain annotations and their functions.
Table 2. Summary of protein domain annotations and their functions.
ProteinsProtein DomainPositionFunction of Each Protein
LEE
Structural
escVPfam:FHIPEP26 to 663It is important for translocation of effector proteins
escDPfam:Yop-YscD_ppl157 to 404It is involved in assembly and function of the T3SS
escUPfam:Bac_export_22 to 241It is important for regulation and stabilization of the apparatus
escNAAA169 to 349It hydrolyses ATP to generate energy required for operation
Pathogenicity
eaeLysM
Pfam: IAT_beta
BID_1
BID_1
BID_2
Pfam: Intimin_C
64 to 113
166 to 442
559 to 648
659 to 746
757 to 835
838 to 939
It is important for mediation of attachment of E. coli to the intestinal epithelium
Core effectors
espAPfam: EspA4 to 186It is important for formation of pilus-like structures that facilitate movement of effectors
espDPfam: SseC117 to 216It forms the pore in the host membrane that allows effectors to move from bacteria into the host
espGPfam: EspG15 to 397It disrupts the host cell processes
non-LEE
cifPfam: CIF81 to 215Interferes with the host cell cycle
nleENleE_fam_methyl 13–168Alters immunological responses and host cell signalling
nleB1None Alters proteins in host cells to affect immune responses
Table 3. Results of SMART validation.
Table 3. Results of SMART validation.
ProteinsQuery CoverageE-ValuePercentage IdentityReference. Accession No.
LEE
escV100%0.0100%WP_001037814.1
escD100%0.099.8%ELP0616342.1
escU100%5 × 10−10299.4%WP_063856070.1
escN100%0.099.8%WP_000622546.1
Eae100%0.0100%WP_000627895.1
espA100%2 × 10−132100%WP_000381555.1
espD100%0.0100%WP_000935768.1
espG100%0.0100%AAC31534.1
non-LEE
Cif100%0.0100%WP_000652080.1
nleE100%1 × 10−119100%WP_000609738.1
nleB1100%0.0100%WP_012578998.1
Table 4. Validation summary of the escV and espA protein structures by the MolProbity software v.4.2.
Table 4. Validation summary of the escV and espA protein structures by the MolProbity software v.4.2.
Ramachandran Plot AnalysisescVespA
MolProbity Score1.381.35
Clash Score2.411.40
Ramachandran Favoured96.14%92.36%
Ramachandran Outliers1.19%0.64%
Rotamer Outliers1.35%0.01%
C-Beta Deviations0177
Bad Bonds0/53844/66,450
Bad Angles24/7285350/89,750
Twisted Non-Proline5/65250/8550
Table 5. Elements of the secondary structure.
Table 5. Elements of the secondary structure.
escVespA
StructureNo. of ResiduesPercentage (%)No. of ResiduesPercentage (%)
Alpha helix (Hh)35552.5913268.75
310 helix (Gg)00.0000.00
Pi helix (Ii)00.0000.00
Beta bridge (Bb)00.0000.00
Extended strand (Ee)11817.4842.08
Beta turn (Tt)375.4800.00
Bend region (Ss)00.0000.00
Random coil (Cc)16524.445629.17
Ambiguous states00.0000.00
Other states00.0000.00
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content.

Share and Cite

MDPI and ACS Style

Malesa, R.; Pierneef, R.; Mafuna, T.; Magwedere, K.; Seakamela, E.; Matle, I. Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System (T3SS) and Core Effector Proteins in Enteropathogenic Escherichia coli (EPEC) Strains Isolated from Food-Producing Animals and Products of Animal Origin. Pathogens 2025, 14, 1099. https://doi.org/10.3390/pathogens14111099

AMA Style

Malesa R, Pierneef R, Mafuna T, Magwedere K, Seakamela E, Matle I. Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System (T3SS) and Core Effector Proteins in Enteropathogenic Escherichia coli (EPEC) Strains Isolated from Food-Producing Animals and Products of Animal Origin. Pathogens. 2025; 14(11):1099. https://doi.org/10.3390/pathogens14111099

Chicago/Turabian Style

Malesa, Refiloe, Rian Pierneef, Thendo Mafuna, Kudakwashe Magwedere, Emmanuel Seakamela, and Itumeleng Matle. 2025. "Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System (T3SS) and Core Effector Proteins in Enteropathogenic Escherichia coli (EPEC) Strains Isolated from Food-Producing Animals and Products of Animal Origin" Pathogens 14, no. 11: 1099. https://doi.org/10.3390/pathogens14111099

APA Style

Malesa, R., Pierneef, R., Mafuna, T., Magwedere, K., Seakamela, E., & Matle, I. (2025). Genome-Based In Silico Analysis of the Structural and Functional Characteristics of the Type Three Secretion System (T3SS) and Core Effector Proteins in Enteropathogenic Escherichia coli (EPEC) Strains Isolated from Food-Producing Animals and Products of Animal Origin. Pathogens, 14(11), 1099. https://doi.org/10.3390/pathogens14111099

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop